These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Intrapartum magnesium sulfate is associated with neuroprotection in growth-restricted fetuses. Stockley EL; Ting JY; Kingdom JC; McDonald SD; Barrett JF; Synnes AR; Monterrosa L; Shah PS; ; ; Am J Obstet Gynecol; 2018 Dec; 219(6):606.e1-606.e8. PubMed ID: 30240651 [TBL] [Abstract][Full Text] [Related]
7. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. Rouse DJ; Hirtz DG; Thom E; Varner MW; Spong CY; Mercer BM; Iams JD; Wapner RJ; Sorokin Y; Alexander JM; Harper M; Thorp JM; Ramin SM; Malone FD; Carpenter M; Miodovnik M; Moawad A; O'Sullivan MJ; Peaceman AM; Hankins GD; Langer O; Caritis SN; Roberts JM; N Engl J Med; 2008 Aug; 359(9):895-905. PubMed ID: 18753646 [TBL] [Abstract][Full Text] [Related]
8. Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis. Conde-Agudelo A; Romero R Am J Obstet Gynecol; 2009 Jun; 200(6):595-609. PubMed ID: 19482113 [TBL] [Abstract][Full Text] [Related]
9. Magnesium sulphate and perinatal mortality and morbidity in very-low-birthweight infants born between 24 and 32 weeks of gestation in Japan. Ohhashi M; Yoshitomi T; Sumiyoshi K; Kawagoe Y; Satoh S; Sameshima H; Ikenoue T Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():140-5. PubMed ID: 27131232 [TBL] [Abstract][Full Text] [Related]
15. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis. Costantine MM; Weiner SJ; Obstet Gynecol; 2009 Aug; 114(2 Pt 1):354-364. PubMed ID: 19622997 [TBL] [Abstract][Full Text] [Related]
16. Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia. Grether JK; Hoogstrate J; Walsh-Greene E; Nelson KB Am J Obstet Gynecol; 2000 Sep; 183(3):717-25. PubMed ID: 10992199 [TBL] [Abstract][Full Text] [Related]
17. Effect of magnesium sulfate administration for neuroprotection on latency in women with preterm premature rupture of membranes. Horton AL; Lai Y; Rouse DJ; Spong CY; Leveno KJ; Varner MW; Mercer BM; Iams JD; Wapner RJ; Sorokin Y; Thorp JM; Ramin SM; Malone FD; O'Sullivan MJ; Hankins GD; Caritis SN; Am J Perinatol; 2015 Mar; 32(4):387-92. PubMed ID: 25241107 [TBL] [Abstract][Full Text] [Related]
18. Preeclampsia, preterm delivery and infant cerebral palsy. Spinillo A; Capuzzo E; Cavallini A; Stronati M; De Santolo A; Fazzi E Eur J Obstet Gynecol Reprod Biol; 1998 Apr; 77(2):151-5. PubMed ID: 9578271 [TBL] [Abstract][Full Text] [Related]
19. School-age outcomes of very preterm infants after antenatal treatment with magnesium sulfate vs placebo. Doyle LW; Anderson PJ; Haslam R; Lee KJ; Crowther C; JAMA; 2014 Sep; 312(11):1105-13. PubMed ID: 25226476 [TBL] [Abstract][Full Text] [Related]
20. Feasibility of implementing magnesium sulphate for neuroprotection in a tertiary obstetric unit. Ow LL; Kennedy A; McCarthy EA; Walker SP Aust N Z J Obstet Gynaecol; 2012 Aug; 52(4):356-60. PubMed ID: 22515404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]